Medical Rehabilitation Research Resource Network

Map of MR3 sites

The National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which is home to the National Center for Medical Rehabilitation Research (NCMRR), in collaboration with the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB), support six P2C resource center grants that provide infrastructure and access to expertise, technologies, and resources to foster clinical and translational research in medical rehabilitation.

Latest News

NCMRR Rehabilitation Research News: June 12, 2020

NIH National Center for Medical Rehabilitation Research (NCMRR)

June 12, 2020

Request for Information (RFI) on Developing an Online Educational Resource for Training in the Principles of Rigorous Research

National Institute of Neurological Disorders and Stroke

May 29, 2020

9th Annual International Symposium on Regenerative Rehabilitation (Dec. 3-5, 2020)

Alliance for Regenerative Rehabilitation Research & Training (AR3T)

May 19, 2020

NCMRR Rehabilitation Research News: May 15,2020

NIH National Center for Medical Rehabilitation Research (NCMRR)

May 15, 2020

Recent Federal Funding Opportunties

Central and Peripheral Control of Balance in Older Adults (R01 Clinical Trial Optional)

(RFA-AG-21-011) National Institute on Aging and National Institute on Deafness and Other Communication Disorders

Application Receipt Date: October 2, 2020

NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)

(PAR-20-084) National Institute of Biomedical Imaging and Bioengineering

Application Receipt Date(s): Application Receipt Date(s): Standard dates apply.

NCMRR Early Career Research Award (R03 Clinical Trial Optional)

(PAR-20-042) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Application Due Date(s): March 30, 2020, March 30, 2021, March 30, 2022

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)

(RFA-NS-20-008) Multiple Institutes

Application Receipt Date(s): January 8, 2020; April 7, 2020; September 9, 2020; January 6, 2021; April 6, 2021; September 8, 2021; January 6, 2022; April 6, 2022; and September 8, 2022

View All